HPV infection in esophageal squamous cell carcinoma and its relationship to the prognosis of patients in Northern China

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Cao, Fangli ^a,b   Han, Hui ^b   Zhang, Fang ^c   Wang, Baozhong ^b   Ma, Wei ^d   Wang, Yanwen ^b   Sun, Guiming ^b   Shi, Miao ^b   Ren, Yubo ^b   Cheng, Yufeng ^a  

^a SHANDONG UNIVERSITY   (China)

^b LIAOCHENG PEOPLE'S HOSPITAL   (China)

^c Central Hospital of Zibo   (China)

^d NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; ARTICLE; CANCER GRADING; CANCER STAGING; CHINA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CHINA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS;

EID: 84893860147     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/804738     Document Type: Article

References (57)

1. Ferlay J., Shin H.-R., Bray F., Forman D., Mathers C., Parkin D. M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010 127 12 2893 2917 2-s2.0-78049485263 10.1002/ijc.25516
2. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
3. Collard J.-M., Otte J.-B., Fiasse R., Laterre P.-F., De Kock M., Longueville J., Glineur D., Romagnoli R., Reynaert M., Kestens P.-J., Skeletonizing en bloc esophagectomy for cancer. Annals of Surgery 2001 234 1 25 32 2-s2.0-0034943786 10.1097/00000658-200107000-00005 (Pubitemid 32619331)
4. Risk J. M., Mills H. S., Garde J., Dunn J. R., Evans K. E., Hollstein M., Field J. K., The tylosis esophageal cancer (TOC) locus: more than just a familial cancer gene. Diseases of the Esophagus 1999 12 3 173 176 2-s2.0-0033381482 10.1046/j.1442-2050.1999.00042.x (Pubitemid 30021386)
5. Wei W.-Q., Yang J., Zhang S.-W., Chen W.-Q., Qiao Y.-L., Analysis of the esophageal cancer mortality in 2004-2005 and its trends during last 30 years in China. Chinese journal of preventive medicine 2010 44 5 398 402 2-s2.0-79952197331
6. Gholipour C., Shalchi R. A., Abbasi M., A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003. Diseases of the Esophagus 2008 21 4 322 327 2-s2.0-43449090120 10.1111/j.1442-2050.2007.00776.x (Pubitemid 351663448)
7. Holmes R. S., Vaughan T. L., Epidemiology and pathogenesis of esophageal cancer. Seminars in Radiation Oncology 2007 17 1 2 9 2-s2.0-33845485257 10.1016/j.semradonc.2006.09.003 (Pubitemid 44918357)
8. Wei W.-Q., Abnet C. C., Qiao Y.-L., Dawsey S. M., Dong Z.-W., Sun X.-D., Fan J.-H., Gunter E. W., Taylor P. R., Mark S. D., Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. The American Journal of Clinical Nutrition 2004 79 1 80 85 2-s2.0-3042785932 (Pubitemid 41132066)
9. Syrjänen K. J., HPV infections and oesophageal cancer. Journal of Clinical Pathology 2002 55 10 721 728 2-s2.0-0036774654 10.1136/jcp.55.10.721 (Pubitemid 35231898)
10. Syrjänen K. J., Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Archiv fur Geschwulstforschung 1982 52 4 283 292 2-s2.0-0020317758 (Pubitemid 12043121)
11. Chang F., Syrjänen S., Shen Q., Cintorino M., Santopietro R., Tosi P., Syrjänen K., Evaluation of HPV, CMV, HSV and EBV in esophageal squamous cell carcinomas from a high-incidence area of China. Anticancer Research 2000 20 5 C 3935 3940 2-s2.0-0034535179 (Pubitemid 32002301)
12. Muñoz N., Bosch F. X., de Sanjosé S., Herrero R., Castellsagué X., Shah K. V., Snijders P. J. F., Meijer C. J. L. M., Epidemiologic classification of human papillomavirus types associated with cervical cancer. The New England Journal of Medicine 2003 348 6 518 527 2-s2.0-0037421589 10.1056/NEJMoa021641 (Pubitemid 36159887)
13. Walboomers J. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer J. A., Shah K. V., Snijders P. J., Peto J., Meijer C. J., Munoz N., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology 1999 189 1 12 19 (Pubitemid 29406813)
14. Naucler P., Chen H.-C., Persson K., You S.-L., Hsieh C.-Y., Sun C.-A., Dillner J., Chen C.-J., Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. Journal of General Virology 2007 88 3 814 822 2-s2.0-33847644663 10.1099/vir.0.82503-0 (Pubitemid 46359550)
15. Meschede W., Zumbach K., Braspenning J., Scheffner M., Benitez-Bribiesca L., Luande J., Gissmann L., Pawlita M., Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. Journal of Clinical Microbiology 1998 36 2 475 480 2-s2.0-0031975141 (Pubitemid 28060316)
16. Herrero R., Castellsagué X., Pawlita M., Lissowska J., Kee F., Balaram P., Rajkumar T., Sridhar H., Rose B., Pintos J., Fernández L., Idris A., Sanchez M. J., Nieto A., Talamini R., Tavani A., Bosch F. X., Reidel U., Snijders P. J. F., Meijer C. J. L. M., Viscidi R., Muñoz N., Franceschi S., Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study. Journal of the National Cancer Institute 2003 95 23 1772 1783 2-s2.0-0346258152 (Pubitemid 38008900)
17. Zumbach K., Hoffmann M., Kahn T., Bosch F., Gottschlich S., Görögh T., Rudert H., Pawlita M., Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head -and-neck squamous-cell carcinoma. International Journal of Cancer 2000 85 6 815 818 (Pubitemid 30131472)
18. D'Souza G., Kreimer A. R., Viscidi R., Pawlita M., Fakhry C., Koch W. M., Westra W. H., Gillison M. L., Case-control study of human papillomavirus and oropharyngeal cancer. The New England Journal of Medicine 2007 356 19 1944 1956 2-s2.0-34248350674 10.1056/NEJMoa065497 (Pubitemid 46740304)
19. Zur Hausen H., Papillomaviruses and cancer: from basic studies to clinical application. Nature Reviews Cancer 2002 2 5 342 350 2-s2.0-0036559896 (Pubitemid 37328947)
20. Münger K., Howley P. M., Human papillomavirus immortalization and transformation functions. Virus Research 2002 89 2 213 228 2-s2.0-0036849734 10.1016/S0168-1702(02)00190-9 (Pubitemid 35351540)
21. Reimers N., Kasper H. U., Weissenborn S. J., Stützer H., Preuss S. F., Hoffmann T. K., Speel E. J. M., Dienes H. P., Pfister H. J., Guntinas-Lichius O., Klussmann J. P., Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. International Journal of Cancer 2007 120 8 1731 1738 2-s2.0-33947140297 10.1002/ijc.22355 (Pubitemid 46399359)
22. Kumar B., Cordell K. G., Lee J. S., Worden F. P., Prince M. E., Tran H. H., Wolf G. T., Urba S. G., Chepeha D. B., Teknos T. N., Eisbruch A., Tsien C. I., Taylor J. M. G., D'Silva N. J., Yang K., Kurnit D. M., Bauer J. A., Bradford C. R., Carey T. E., EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. Journal of Clinical Oncology 2008 26 19 3128 3137 2-s2.0-49249095295 10.1200/JCO.2007.12.7662
23. Fakhry C., Westra W. H., Li S., Cmelak A., Ridge J. A., Pinto H., Forastiere A., Gillison M. L., Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. Journal of the National Cancer Institute 2008 100 4 261 269 2-s2.0-39649109915 10.1093/jnci/djn011 (Pubitemid 351480538)
24. Licitra L., Perrone F., Bossi P., Suardi S., Mariani L., Artusi R., Oggionni M., Rossini C., Cantù G., Squadrelli M., Quattrone P., Locati L. D., Bergamini C., Olmi P., Pierotti M. A., Pilotti S., High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. Journal of Clinical Oncology 2006 24 36 5630 5636 2-s2.0-34247331367 10.1200/JCO.2005.04.6136 (Pubitemid 46631302)
25. Smeets S. J., Hesselink A. T., Speel E.-J. M., Haesevoets A., Snijders P. J. F., Pawlita M., Meijer C. J. L. M., Braakhuis B. J. M., Leemans C. R., Brakenhoff R. H., A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. International Journal of Cancer 2007 121 11 2465 2472 2-s2.0-35648937953 10.1002/ijc.22980 (Pubitemid 350022416)
26. Syrjänen S., HPV infections and tonsillar carcinoma. Journal of Clinical Pathology 2004 57 5 449 455 2-s2.0-2442428503 10.1136/jcp.2003.008656 (Pubitemid 38621787)
27. Kong C. S., Narasimhan B., Cao H., Kwok S., Erickson J. P., Koong A., Pourmand N., Le Q.-T., The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. International Journal of Radiation Oncology Biology Physics 2009 74 2 553 561 2-s2.0-65449131740 10.1016/j.ijrobp.2009.02.015
28. Weinberger P. M., Yu Z., Haffty B. G., Kowalski D., Harigopal M., Brandsma J., Sasaki C., Joe J., Camp R. L., Rimm D. L., Psyrri A., Molecular classification identifies a subset of human papillomavirus- associated oropharyngeal cancers with favorable prognosis. Journal of Clinical Oncology 2006 24 5 736 747 2-s2.0-33644849030 10.1200/JCO.2004.00.3335 (Pubitemid 46622040)
29. Hippeläinen M., Eskelinen M., Lipponen P., Chang F., Syrjänen K., Mitotic activity index, volume corrected mitotic index and human papilloma-virus suggestive morphology are not prognostic factors in carcinoma of the oesophagus. Anticancer Research 1993 13 3 677 681 2-s2.0-0027217109 (Pubitemid 23216966)
30. Furihata M., Ohtsuki Y., Ogoshi S., Takahashi A., Tamiya T., Ogata T., Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. International Journal of Cancer 1993 54 2 226 230 2-s2.0-0027168541 10.1002/ijc.2910540211 (Pubitemid 23154886)
31. Dreilich M., Bergqvist M., Moberg M., Brattström D., Gustavsson I., Bergström S., Wanders A., Hesselius P., Wagenius G., Gyllensten U., High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study. BMC Cancer 2006 6, article 94 2-s2.0-33744934750 10.1186/1471-2407-6-94 (Pubitemid 43842141)
32. Zheng S., Vuitton L., Sheyhidin I., Vuitton D. A., Zhang Y., Lu X., Northwestern China: a place to learn more on oesophageal cancer. Part one: behavioural and environmental risk factors. European Journal of Gastroenterology and Hepatology 2010 22 8 917 925 2-s2.0-77955232436 10.1097/MEG. 0b013e3283313d8b
33. Saqi A., Pasha T. L., McGrath C. M., Yu G. H., Zhang P., Gupta P., Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Diagnostic Cytopathology 2002 27 6 365 370 2-s2.0-0036895918 10.1002/dc.10205 (Pubitemid 35424172)
34. Michiels S., Le Maître A., Buyse M., Burzykowski T., Maillard E., Bogaerts J., Vermorken J. B., Budach W., Pajak T. F., Ang K. K., Bourhis J., Pignon J.-P., Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data. The Lancet Oncology 2009 10 4 341 350 2-s2.0-63149095503 10.1016/S1470-2045(09)70023-3
35. Reed A. L., Califano J., Cairns P., Westra W. H., Jones R. M., Koch W., Ahrendt S., Eby Y., Sewell D., Nawroz H., Bartek J., Sidransky D., High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Research 1996 56 16 3630 3633 2-s2.0-9444255067 (Pubitemid 26272001)
36. zur Hausen H., Papillomaviruses in the causation of human cancers-a brief historical account. Virology 2009 384 2 260 265 2-s2.0-59349121140 10.1016/j.virol.2008.11.046
37. Muñoz N., Human papillomavirus and cancer: the epidemiological evidence. Journal of Clinical Virology 2000 19 1-2 1 5 2-s2.0-0033728049 10.1016/S1386-6532(00)00125-6
38. Moberg M., Gustavsson I., Gyllensten U., Real-time pcr-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. Journal of Clinical Microbiology 2003 41 7 3221 3228 2-s2.0-0037830414 10.1128/JCM.41.7.3221-3228.2003 (Pubitemid 36842325)
39. Mork J., Lie A. K., Glattre E., Hallmans G., Jellum E., Koskela P., Møller B., Pukkala E., Schiller J. T., Youngman L., Lehtinen M., Dillner J., Clark S., Wang Z., Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. The New England Journal of Medicine 2001 344 15 1125 1131 2-s2.0-0035849153 10.1056/NEJM200104123441503 (Pubitemid 32285233)
40. Shen Z.-Y., Hu S.-P., Lu L.-C., Tang C.-Z., Kuang Z.-S., Zhong S.-P., Zeng Y., Detection of human papillomavirus in esophageal carcinoma. Journal of Medical Virology 2002 68 3 412 416 2-s2.0-0036836523 10.1002/jmv.10219
41. Gao Y., Hu N., Han X., Giffen C., Ding T., Goldstein A., Taylor P., Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer 2009 9, article 269 2-s2.0-69249179575 10.1186/1471-2407-9-269
42. Wen D., Shan B., Wang S., Zhang L., Wei L., Zhou W., Peng Q., A positive family history of esophageal/gastric cardia cancer with gastric cardia adenocarcinoma is associated with a younger age at onset and more likely with another synchronous esophageal/gastric cardia cancer in a Chinese high-risk area. European Journal of Medical Genetics 2010 53 5 250 255 2-s2.0-77956895711 10.1016/j.ejmg.2010.06.011
43. Baseman J. G., Koutsky L. A., The epidemiology of human papillomavirus infections. Journal of Clinical Virology 2005 32 S16 S24 2-s2.0-14744293594 10.1016/j.jcv.2004.12.008 (Pubitemid 40332585)
44. Herbenick D., Reece M., Schick V., Sanders S. A., Dodge B., Fortenberry J. D., Sexual behavior in the United States: results from a national probability sample of men and women ages 14-94. Journal of Sexual Medicine 2010 7 5 255 265 2-s2.0-77957359344 10.1111/j.1743-6109.2010.02012.x
45. Bajos N., Bozon M., Beltzer N., Laborde C., Andro A., Ferrand M., Goulet V., Laporte A., Le Van C., Leridon H., Levinson S., Razafindratsima N., Toulemon L., Warszawski J., Wellings K., Changes in sexual behaviours: from secular trends to public health policies. AIDS 2010 24 8 1185 1191 2-s2.0-77951878215 10.1097/QAD.0b013e328336ad52
46. de Vuyst H., Clifford G. M., Nascimento M. C., Madeleine M. M., Franceschi S., Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. International Journal of Cancer 2009 124 7 1626 1636 2-s2.0-61449242932 10.1002/ijc.24116
47. Parkin D. M., Bray F., Ferlay J., Pisani P., Global cancer statistics, 2002. CA Cancer Journal for Clinicians 2005 55 2 74 108 2-s2.0-14944385553 (Pubitemid 40372904)
48. Gillison M. L., Koch W. M., Capone R. B., Spafford M., Westra W. H., Wu L., Zahurak M. L., Daniel R. W., Viglione M., Symer D. E., Shah K. V., Sidransky D., Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. Journal of the National Cancer Institute 2000 92 9 709 720 2-s2.0-0034600339 (Pubitemid 30365531)
49. Ang K. K., Harris J., Wheeler R., Weber R., Rosenthal D. I., Nguyen-Tân P. F., Westra W. H., Chung C. H., Jordan R. C., Lu C., Kim H., Axelrod R., Silverman C. C., Redmond K. P., Gillison M. L., Human papillomavirus and survival of patients with oropharyngeal cancer. The New England Journal of Medicine 2010 363 1 24 35 2-s2.0-77954190940 10.1056/NEJMoa0912217
50. Pestell K. E., Hobbs S. M., Titley J. C., Kelland L. R., Walton M. I., Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line. Molecular Pharmacology 2000 57 3 503 511 2-s2.0-0034006177 (Pubitemid 30140880)
51. Begum S., Cao D., Gillison M., Zahurak M., Westra W. H., Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clinical Cancer Research 2005 11 16 5694 5699 2-s2.0-23844532582 10.1158/1078-0432.CCR-05-0587 (Pubitemid 41170292)
52. McGovern S. L., Williams M. D., Weber R. S., Sabichi A., Chambers M. S., Martin J. W., Chao K. S. C., Three synchronous HPV-associated squamous cell carcinomas of Waldeyer's ring: case report and comparison with Slaughter's model of field cancerization. Head and Neck 2010 32 8 1118 1124 2-s2.0-77955592433 10.1002/hed.21171
53. Wansom D., Light E., Thomas D., Worden F., Prince M., Urba S., Chepeha D., Kumar B., Cordell K., Eisbruch A., Taylor J., Moyer J., Bradford C., D'Silva N., Carey T., McHugh J., Wolf G., Infiltrating lymphocytes and human papillomavirus-16-associated oropharyngeal cancer. The Laryngoscope 2012 122 1 121 127 2-s2.0-84255204907 10.1002/lary.22133
54. Dahlgren L., Mellin H., Wangsa D., Heselmeyer-Haddad K., Björnestal L., Lindholm J., Munck-Wikland E., Auer G., Ried T., Dalianis T., Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors. International Journal of Cancer 2003 107 2 244 249 2-s2.0-0141523103 10.1002/ijc.11371 (Pubitemid 37152904)
55. Hecht S. S., Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbeck's Archives of Surgery 2006 391 6 603 613 2-s2.0-33750439870 10.1007/s00423-006-0111-z (Pubitemid 44657742)
56. Schwartz S. M., Daling J. R., Doody D. R., Wipf G. C., Carter J. J., Madeleine M. M., Mao E.-J., Fitzgibbons E. D., Huang S., Beckmann A. M., McDougall J. K., Galloway D. A., Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. Journal of the National Cancer Institute 1998 90 21 1626 1636 2-s2.0-0032483740 (Pubitemid 28523437)
57. Applebaum K. M., Furniss C. S., Zeka A., Posner M. R., Smith J. F., Bryan J., Eisen E. A., Peters E. S., McClean M. D., Kelsey K. T., Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. Journal of the National Cancer Institute 2007 99 23 1801 1810 2-s2.0-38449084000 10.1093/jnci/djm233 (Pubitemid 351767210)